Companies / Ultromics
Ultromics provides FDA-cleared AI that analyzes routine echocardiograms to help identify patients with HFpEF and cardiac amyloidosis. It serves clinicians and hospitals, integrating into existing echo workflows.
Summarized from its homepage on 12 Nov 2026.
Vendors of Ultromics and the evidence for each
VendorCategoryEvidenceLevel
CloudflareCloud and infrastructureLikely
Google AdsAdvertisingLikely
Google AnalyticsAnalyticsLikely
Google Tag ManagerAnalyticsLikely
Website
Companies using Google Tag Managerscript: c= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f12 Nov 2026Source
HotjarAnalyticsLikely
HubSpotCRM and salesLikely
Website
Companies using HubSpotscript: ion/ssr',u='https://js.hsforms.net/forms/embed/7706084.js') => { con12 Nov 2026Source
LinkedIn Insight TagAdvertisingLikely
Website
Companies using LinkedIn Insight Tagscript: ; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBe12 Nov 2026Source
Microsoft 365ProductivityLikely
No public list found
We did not find a public subprocessor list. The company may still publish one, or share it privately.
Vendor's own statement, retrieved from the source URL on the date shown. StrataDB does not verify the underlying claim. Data sources.
See Ultromics's full stack
Every vendor with its source and date, and an alert when Ultromics adds or drops one. The same lookup works for any company.
- Every company and vendor, with its public source
- 100 API calls a month, plus MCP and the Chrome extension
- Work email only. No card, no sales call